Clinical characteristics and prognostic factors of Hurthle cell carcinoma: a population based study

被引:23
|
作者
Zhou, Xingtong [1 ]
Zheng, Zhibo [2 ]
Chen, Chuyan [3 ]
Zhao, Bangbo [4 ]
Cao, Hongtao [4 ]
Li, Tianhao [4 ]
Liu, Xudong [5 ]
Wang, Weibin [4 ]
Li, Yongning [2 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Breast Surg, Beijing, Peoples R China
[2] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Int Med Serv, Beijing, Peoples R China
[3] Chinese Acad Med Sci, Peking Union Med Coll, Beijing, Peoples R China
[4] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Gen Surg, 1 Shuaifuyuan Wangfujing, Beijing, Peoples R China
[5] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Med Sci Res Ctr, Beijing, Peoples R China
基金
中国国家自然科学基金;
关键词
Thyroid Hurthle cell carcinoma; SEER database; Survival factors; SURVIVAL; RECURRENCE; TUMORS; LEVEL;
D O I
10.1186/s12885-020-06915-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundThyroid Hurthle cell carcinoma (HCC) is a rare disease with high risk of invasion and metastasis and poor prognosis. The clinical characteristics, prognosis and treatment of HCC are still controversial, and clinical data are still limited to some case reports. Therefore, understanding the characteristics and survival factors of HCC is clinically necessary.MethodsThis study collected data from HCC patients diagnosed pathologically from 2004 to 2015, including basic population characteristics, tumor characteristics, and epidemiological and survival data. The data were extracted from the Surveillance, Epidemiology, and End Results (SEER) database to conduct a population cohort study.ResultsA total of 2101 HCC patients with an average age of 55.4215.27years were enrolled in this study. Of them, 1740 (82.82%) patients had local disease, 245 (11.66%) had regional disease, and 89 (4.24%) had distant disease. Total thyroidectomy was performed in 1669 (79.44%) patients, partial thyroidectomy was performed in 382 (18.18%) patients, and radioactive iodine (RAI) was used in 1155 (54.97%) patients. The 5-year and 10-year cancer-specific survival rate was 95.4 and 92.6%, respectively. The distant disease group had significantly more male patients, multifocal tumors, and extensive tumors compared to the local disease group. Multivariate survival analysis showed that age (P<0.05), SEER stage (P<0.001), and T-stage (P=0.001) had significant effects on survival. There was no significant difference in survival between total and partial thyroidectomy (P=0.078), or between RAI and non-RAI (P=0.733).Conclusion p id=Par Male gender, multifocal tumors, and extended tumors are associated with increased risk of late stage HCC. Age over 45years, distant SEER stage, and late T-stage are independent risk factors for mortality in HCC.
引用
收藏
页数:9
相关论文
共 50 条
  • [41] A PILOT STUDY OF MOLECULAR ALTERATIONS AND THE CLINICAL PROGNOSTIC FACTORS OF CHOLANGIO-CARCINOMA IN THE THAI POPULATION
    Detarkom, S.
    Trachu, N.
    Larbcharoensub, N.
    Monnamo, N.
    Jinawat, A.
    Kamprerasart, K.
    MunTham, D.
    Sirachainan, E.
    Reungwetwattana, T.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 : E9 - E9
  • [42] Epidemiology of and prognostic factors for patients with sarcomatoid carcinoma: a large population-based study
    Xu, Zihan
    Wang, Li
    Tu, Li
    Liu, Yanyang
    Xie, Xiaoxiao
    Tang, Xiaojun
    Luo, Feng
    AMERICAN JOURNAL OF CANCER RESEARCH, 2020, 10 (11): : 3801 - +
  • [43] Thyroid Hurthle Cell Carcinoma: Clinical, Pathological, and Molecular Features
    Kure, Shoko
    Ohashi, Ryuji
    CANCERS, 2021, 13 (01) : 1 - 14
  • [44] Epidemiology, prognostic factors, and survival analysis in small cell esophageal carcinoma: A population-based study with external validation
    Zhu, Jiahao
    Xu, Benjie
    Li, Yuanyuan
    Pang, Xiangyi
    Ji, Shengjun
    Lian, Jie
    Lu, Haibo
    BIOMOLECULES AND BIOMEDICINE, 2024,
  • [45] Hurthle Cell Carcinoma A Population-Level Analysis of 3311 Patients
    Goffredo, Paolo
    Roman, Sanziana A.
    Sosa, Julie A.
    CANCER, 2013, 119 (03) : 504 - 511
  • [46] Hurthle cell carcinoma:: a clinicopathological study of thirteen cases
    Küçük, NÖ
    Kulak, H
    Tokmak, E
    Tari, P
    Ibis, E
    Aras, G
    NUCLEAR MEDICINE COMMUNICATIONS, 2006, 27 (04) : 377 - 379
  • [47] Clinical and pathological prognostic factors in squamous cell carcinoma of the vulva
    Raspagliesi, Francesco
    Hanozet, Francesco
    Ditto, Antonino
    Solima, Eugenio
    Zanaboni, Flavia
    Vecchione, Francesca
    Kusamura, Shigeki
    GYNECOLOGIC ONCOLOGY, 2006, 102 (02) : 333 - 337
  • [48] Clinical and pathological prognostic factors in Merkel cell carcinoma.
    Tovazzi, Valeria
    Lorini, Luigi
    Battocchio, Simonetta
    Zannoni, Marina
    Paolino, Gaetano
    Cingarlini, Sara
    Zamparini, Manuel
    Tomasoni, Michele
    Ravanelli, Marco
    Oberti, Arianna
    Grammatica, Alberto
    Buglione, Michela
    Magrini, Stefano M.
    Maroldi, Roberto
    Piazza, Cesare
    Facchetti, Fabio
    Scarpa, Aldo
    Berruti, Alfredo
    Bossi, Paolo
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [49] Clinical course and prognostic factors of Merkel cell carcinoma of the skin
    Gueler-Nizam, E.
    Leiter, U.
    Metzler, G.
    Breuninger, H.
    Garbe, C.
    Eigentler, T. K.
    BRITISH JOURNAL OF DERMATOLOGY, 2009, 161 (01) : 90 - 94
  • [50] Prognostic Factors for Disease-free Survival in 97 Patients with Hurthle Cell Thyroid Carcinoma - A Single Institution Experience
    Vidergar-Kralj, B.
    Besic, N.
    Petric, R.
    Gazic, B.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S460 - S461